RxDoctor Payments Data

Emily Liddell

Family · Memphis, TNNPI 1801584891

Payments from drug & device makers

$7,055in general payments, 2019–2025

Across 372 payments — averaging $18.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$790
  • UCB, Inc.$769
  • Neurocrine Biosciences, Inc.$607
  • Novartis$502
  • SK Life Science, Inc.$479
  • EMD Serono, Inc.$385
  • plus $4K from 24 others

What the payments were for

  • Food & beverage$7,055100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,055 in reported general payments places this provider in the 90th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Most prescribed under Part D

DrugClaimsCost to plans & patients
QuliptaAtogepant18$21,057
Emgality PenGalcanezumab-Gnlm27$18,062
XcopriCenobamate15$17,337
UbrelvyUbrogepant14$16,552
Aimovig AutoinjectorErenumab-Aooe16$13,446
Lacosamide30$3,425
Levetiracetam80$2,294
Memantine Hcl120$1,940
Gabapentin171$1,865
Pregabalin96$1,789
Carbidopa-Levodopa ErCarbidopa/Levodopa27$1,162
Primidone84$1,137
Tizanidine Hcl89$1,029
Duloxetine Hcl63$1,022
Amitriptyline Hcl108$956

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieQulipta, Ubrelvy$213$37,60932 claims
SK Life Science, Inc.Xcopri$479$17,33715 claims
Lilly USA, LLCOlanzapine$369$28923 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,706 family providers in Tennessee.

Other family in Memphis

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →